Literature DB >> 18220271

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity.

ZhengZheng Li1, Michael Berk, Thomas M McIntyre, Gregory J Gores, Ariel E Feldstein.   

Abstract

UNLABELLED: Impaired mitochondrial function is largely thought to be a core abnormality responsible for disease progression in nonalcoholic fatty liver disease (NAFLD). However, the molecular mechanisms resulting in mitochondrial dysfunction in NAFLD remain poorly understood. This study examined the effects of excessive accumulation of free fatty acids (FFAs) in liver cells on mitochondrial function and the role of the lysosomal-mitochondrial axis on lipotoxicity. Primary mouse hepatocytes, HepG2 and McNtcp.24 cells, were treated with varied concentrations of FFAs with different degrees of saturation for up to 24 hours. Mitochondrial function was monitored by real-time imaging, cytochrome c redistribution, and reactive oxygen species (ROS) production. The temporal relationship of lysosomal and mitochondrial permeabilization was established. Activity of the lysosomal protease cathepsin B was suppressed by genetic and pharmacological approaches. Cathepsin B-knockout mice and wild-type animals were place on a high-carbohydrate diet for 16 weeks, and mitochondrial function and liver damage were assessed. Exposure of liver cells to saturated FFAs resulted in mitochondrial depolarization, cytochrome c release, and increased ROS production. Lysosomal permeabilization and cathepsin B redistribution into the cytoplasm occurred several hours prior to mitochondrial dysfunction. Either pharmacological or genetic inhibition of cathepsin B preserved mitochondrial function. Finally, cathepsin B inactivation protected mitochondria, decreased oxidative stress, and attenuated hepatic injury in vivo.
CONCLUSION: These data strongly suggest excessive accumulation of saturated FFAs in liver cells directly induce mitochondrial dysfunction and oxidative stress. Our data further suggest this process is dependent on lysosomal disruption and activation of cathepsin B.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18220271      PMCID: PMC3025414          DOI: 10.1002/hep.22183

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  31 in total

Review 1.  Apoptotic pathways: the roads to ruin.

Authors:  D R Green
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

2.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

3.  Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.

Authors:  M Shimabukuro; Y T Zhou; M Levi; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Studies on fatty acid metabolism in diabetics during exercise. V. Plasma concentration of free fatty acids and glycerol in newly diagnosed, adult diabetics during exercise.

Authors:  S Carlström
Journal:  Acta Med Scand       Date:  1967-09

5.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

Review 6.  Mitochondrial injury in steatohepatitis.

Authors:  Dominique Pessayre; Bernard Fromenty; Abdellah Mansouri
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-11       Impact factor: 2.566

Review 7.  Mitochondria in nonalcoholic fatty liver disease.

Authors:  Stephen H Caldwell; Charissa Y Chang; Robert K Nakamoto; Lisa Krugner-Higby
Journal:  Clin Liver Dis       Date:  2004-08       Impact factor: 6.126

Review 8.  Molecular mediators of hepatic steatosis and liver injury.

Authors:  Jeffrey D Browning; Jay D Horton
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

9.  Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens.

Authors:  Elizabeth M Brunt; Brent A Neuschwander-Tetri; Dana Oliver; Kent R Wehmeier; Bruce R Bacon
Journal:  Hum Pathol       Date:  2004-09       Impact factor: 3.466

10.  Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.

Authors:  Ariel E Feldstein; Nathan W Werneburg; Ali Canbay; Maria Eugenia Guicciardi; Steven F Bronk; Robert Rydzewski; Laurence J Burgart; Gregory J Gores
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

View more
  102 in total

1.  SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity.

Authors:  Jianjun Bao; Iain Scott; Zhongping Lu; Liyan Pang; Christopher C Dimond; David Gius; Michael N Sack
Journal:  Free Radic Biol Med       Date:  2010-07-18       Impact factor: 7.376

Review 2.  The role of lysosome in cell death regulation.

Authors:  Feifei Yu; Zongyan Chen; Benli Wang; Zhao Jin; Yufei Hou; Shumei Ma; Xiaodong Liu
Journal:  Tumour Biol       Date:  2015-12-02

Review 3.  Lipotoxicity in the liver.

Authors:  Veronika Zámbó; Laura Simon-Szabó; Péter Szelényi; Eva Kereszturi; Gábor Bánhegyi; Miklós Csala
Journal:  World J Hepatol       Date:  2013-10-27

4.  Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis.

Authors:  S C Cazanave; X Wang; H Zhou; M Rahmani; S Grant; D E Durrant; C D Klaassen; M Yamamoto; A J Sanyal
Journal:  Cell Death Differ       Date:  2014-04-25       Impact factor: 15.828

Review 5.  Glycosphingolipids and cell death: one aim, many ways.

Authors:  Carmen Garcia-Ruiz; Albert Morales; José C Fernández-Checa
Journal:  Apoptosis       Date:  2015-05       Impact factor: 4.677

6.  Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome.

Authors:  Takuma Misawa; Michihiro Takahama; Tatsuya Kozaki; Hanna Lee; Jian Zou; Tatsuya Saitoh; Shizuo Akira
Journal:  Nat Immunol       Date:  2013-03-17       Impact factor: 25.606

7.  The effect of tert-butyl hydroperoxide-induced oxidative stress on lean and steatotic rat hepatocytes in vitro.

Authors:  Otto Kučera; René Endlicher; Tomáš Roušar; Halka Lotková; Tomáš Garnol; Zdeněk Drahota; Zuzana Cervinková
Journal:  Oxid Med Cell Longev       Date:  2014-03-31       Impact factor: 6.543

8.  Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis.

Authors:  Michael K Pickens; Jim S Yan; Raymond K Ng; Hisanobu Ogata; James P Grenert; Carine Beysen; Scott M Turner; Jacquelyn J Maher
Journal:  J Lipid Res       Date:  2009-03-17       Impact factor: 5.922

9.  Lysosomal instability and cathepsin B release during acetaminophen hepatotoxicity.

Authors:  Benjamin L Woolbright; Anup Ramachandran; Mitchell R McGill; Hui-min Yan; Mary Lynn Bajt; Matthew R Sharpe; John J Lemasters; Hartmut Jaeschke
Journal:  Basic Clin Pharmacol Toxicol       Date:  2012-09-25       Impact factor: 4.080

10.  The plasma lipidomic signature of nonalcoholic steatohepatitis.

Authors:  Puneet Puri; Michelle M Wiest; Onpan Cheung; Faridoddin Mirshahi; Carol Sargeant; Hae-Ki Min; Melissa J Contos; Richard K Sterling; Michael Fuchs; Huiping Zhou; Steven M Watkins; Arun J Sanyal
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.